We do not sell a single “comprehensive” panel. Each panel is curated to answer a specific peptide-candidacy question — the assays included exist to inform a published-protocol decision, not to maximize line items. Choose by the question you came to ask, or order the Complete Atlas.
For athletes evaluating BPC-157, TB-500, or related repair peptides. Quantifies systemic inflammation and tissue-injury markers.
Anchored on IGF-1 to evaluate candidacy for GHRH/GHRP combinations. Includes a pituitary safety screen and metabolic baseline.
Determines candidacy and baseline for GLP-1 / dual-incretin therapy. Screens for contraindications including calcitonin and lipase.
Hypothalamic–pituitary–gonadal axis with prolactin and SHBG. Distinguishes hormonal from neurogenic etiology before PT-141 candidacy.
Every assay across recovery, growth, metabolic, sexual, and cardiovascular axes. The full atlas — the panel run in this issue’s cover report.
For complex cases — prior peptide use, chronic disease overlap, or cross-system signals. Includes a custom panel design, an extended report, and one follow-up consultation at week 12.
| Biomarker | Recovery $149 | Growth Axis $199 | Metabolic $179 | Sexual Health $169 | Complete $349 |
|---|---|---|---|---|---|
| Growth axis | |||||
| IGF-1 | — | ● | — | — | ● |
| IGFBP-3 | — | ● | — | — | ● |
| Prolactin | — | ● | — | ● | ● |
| Metabolic | |||||
| HbA1c | — | ● | ● | — | ● |
| Fasting insulin | — | ● | ● | — | ● |
| C-peptide | — | — | ● | — | ● |
| Calcitonin (rule-out) | — | — | ● | — | ● |
| Lipase | — | — | ● | — | ● |
| Inflammation | |||||
| hsCRP | ● | — | — | — | ● |
| Ferritin | ● | — | — | — | ● |
| IL-6 | ● | — | — | — | ● |
| HPG axis | |||||
| Total testosterone | — | — | — | ● | ● |
| Free testosterone | — | — | — | ● | ● |
| SHBG | — | — | — | ● | ● |
| LH / FSH | — | — | — | ● | ● |
| Cardiovascular | |||||
| Apo B | — | — | — | — | ● |
| Lp(a) | — | — | — | — | ● |
| Homocysteine | — | — | — | — | ● |